Image-guided thermal ablation of central renal tumors with retrograde cold pyeloperfusion technique: a monocentric experience

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Lightfoot N, Conlon M, Kreiger N, et al. Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol. 2000;37:521–527.
   PubMed Web of Science ®Google Scholar
• Gill IS, Aron M, Gervais DA, et al. Clinical practice. Small renal mass. N Engl J Med. 2010;362:624–634.
   PubMed Web of Science ®Google Scholar
• Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520–529.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67:913–924.
   PubMed Web of Science ®Google Scholar
• Atwell TD, Schmit GD, Boorjian SA, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2013;200:461–466.
   PubMed Web of Science ®Google Scholar
• Ginzburg S, Tomaszewski JJ, Kutikov A. Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy. Nat Rev Urol. 2017;14:669–682.
   PubMed Web of Science ®Google Scholar
• Sartori S, Mauri G, Tombesi P, et al. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk. Int J Hyperthermia. 2018;35:19–25.
   PubMed Web of Science ®Google Scholar
• Filippiadis D, Mauri G, Marra P, et al. Percutaneous ablation techniques for renal cell carcinoma: current status and future trends. Int J Hyperthermia. 2019;36:21–30.
   PubMed Web of Science ®Google Scholar
• Gervais DA, Arellano RS, McGovern FJ, et al. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. Am J Roentgenol. 2005;185:72–80.
   PubMed Web of Science ®Google Scholar
• Ruiz VA, Lönnemark M, Brekkan E, et al. Predictive factors for complete renal tumor ablation using RFA. Acta Radiol. 2016;57:886–893.
   PubMed Web of Science ®Google Scholar
• Johnson DB, Saboorian MH, Duchene DA, et al. Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology. 2003;62:351–352.
   PubMed Web of Science ®Google Scholar
• Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007;188:1195–1200.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Varano GM, et al. Unusual tumour ablations: report of difficult and interesting cases. Ecancermedicalscience. 2017;11:733.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Varano GM, et al. Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation. Insights Imaging. 2017;8:357–363.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al.; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273:241–260.
   PubMed Web of Science ®Google Scholar
• Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–853.
   PubMed Web of Science ®Google Scholar
• Gervais DA, McGovern FJ, Wood BJ, et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology. 2000;217:665–672.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:199–202.
   PubMed Web of Science ®Google Scholar
• Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:706–720.
   PubMed Web of Science ®Google Scholar
• Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008;19:1034–1040.
   PubMed Web of Science ®Google Scholar
• Schultze D, Morris CS, Bhave AD, et al. Radiofrequency ablation of renal transitional cell carcinoma with protective cold saline infusion. J Vasc Interv Radiol. 2003;14:489–492.
   PubMed Web of Science ®Google Scholar
• Glamore M, Masterson T, Pease KJ, et al. Mathematical and ex vivo thermal modeling for renal tumor radiofrequency ablation with pyeloperfusion. J Endourol. 2015;29:707–713.
   PubMed Web of Science ®Google Scholar
• Margulis V, Matsumoto ED, Taylor G, et al. Retrograde renal cooling during radio frequency ablation to protect from renal collecting system injury. J Urol. 2005;174:350–352.
   PubMed Web of Science ®Google Scholar
• Hwang S, Il Cho JY, Kim SH, et al. Protection of the renal collecting system during radiofrequency ablation with antegrade cold dextrose infusion. Radiology. 2010;256:759–766.
   PubMed Web of Science ®Google Scholar
• Isfort P, Penzkofer T, Tanaka T, et al. Efficacy of antegrade pyeloperfusion to protect the renal pelvis in kidney microwave ablation using an in vivo swine model. Invest Radiol. 2013;48:863–868.
   PubMed Web of Science ®Google Scholar
• Eswara JR, Gervais DA, Mueller PR, et al. Renal radiofrequency ablation with pyeloperfusion. Int J Urol. 2015;22:131–132.
   PubMed Web of Science ®Google Scholar
• Samadi K, Arellano R. Comparison of clinical outcome between pyeloperfused versus non-pyeloperfused microwave ablation of renal cell carcinoma. Pol J Radiol. 2019;84:e447–e452.
   PubMed Web of Science ®Google Scholar
• Rouvière O, Badet L, Murat FJ, et al. Radiofrequency ablation of renal tumors with an expandable multitined electrode: Results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection. Cardiovasc Intervent Radiol. 2008;31:595–603.
   PubMed Web of Science ®Google Scholar
• Dai Y, Covarrubias D, Uppot R, et al. Image-guided percutaneous radiofrequency ablation of central renal cell carcinoma: assessment of clinical efficacy and safety in 31 tumors. J Vasc Interv Radiol. 2017;28:1643–1650.
   PubMed Web of Science ®Google Scholar
• Marshall HR, Shakeri S, Hosseiny M, et al. Long-term survival after percutaneous radiofrequency ablation of pathologically proven renal cell carcinoma in 100 patients. J Vasc Interv Radiol. 2020;31:15–24.
   PubMed Web of Science ®Google Scholar
• Samadi K, Arellano RS. Ureteral protection during microwave ablation of renal cell carcinoma: combined use of pyeloperfusion and hydrodissection. Diagn Interv Radiol. 2018;24:388–391.
   PubMed Web of Science ®Google Scholar
• Klapperich ME, Abel EJ, Ziemlewicz TJ, et al. Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: a single-center, retrospective study. Radiology. 2017;284:272–280.
   PubMed Web of Science ®Google Scholar
• Mauri G, Porazzi E, Cova L, et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5:209–216.
   PubMedGoogle Scholar
• Monfardini L, Gennaro N, Della Vigna P, et al. Cone-beam CT-assisted ablation of renal tumors: preliminary results. Cardiovasc Intervent Radiol. 2019;42:1718–1725.
   PubMed Web of Science ®Google Scholar
• Mauri G. Expanding role of virtual navigation and fusion imaging in percutaneous biopsies and ablation. Abdom Imaging. 2015;40:3238–3239.
   PubMedGoogle Scholar
• Mauri G, Gennaro N, De Beni S, et al. Real-time US-18FDG-PET/CT image fusion for guidance of thermal ablation of 18FDG-PET-positive liver metastases: the added value of contrast enhancement. Cardiovasc Intervent Radiol. 2019;42:60–68.
   PubMed Web of Science ®Google Scholar
• Mauri G, De Beni S, Forzoni L, et al. Virtual navigator automatic registration technology in abdominal application. Conf Proc IEEE Eng Med Biol Soc. 2014; 2014:5570–5574.
   PubMedGoogle Scholar
• Breen DJ, King AJ, Patel N, et al. Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology. 2018;289:554–561.
   PubMed Web of Science ®Google Scholar
• Zargar H, Atwell TD, Cadeddu JA, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69:116–128.
   PubMed Web of Science ®Google Scholar
• Zondervan PJ, Buijs M, de la Rosette JJ, et al. Cryoablation of small kidney tumors. Int J Surg. 2016;36:533–540.
   PubMed Web of Science ®Google Scholar
• Patel N, Cranston D, Akhtar MZ, et al. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy. BJU Int. 2012;110:1270–1275.
   PubMed Web of Science ®Google Scholar
• Baust JG, Gage AA, Bjerklund Johansen TE, et al. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology. 2014;68:1–11.
   PubMed Web of Science ®Google Scholar
• Littrup PJ, Ahmed A, Aoun HD, et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007;18:383–392.
   PubMed Web of Science ®Google Scholar
• West B, Keheila M, Smith JC, et al. Efficacy of antegrade and retrograde warm saline pyeloperfusion during renal cryoablation for ureteral preservation. Turk J Urol. 2018;44:142–147.
   PubMed Web of Science ®Google Scholar